nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—ABCB1—ovarian cancer	0.16	1	CbGaD
Nifedipine—ABCC3—Doxorubicin—ovarian cancer	0.0448	0.0965	CbGbCtD
Nifedipine—ABCC2—Paclitaxel—ovarian cancer	0.0378	0.0814	CbGbCtD
Nifedipine—ABCC2—Carboplatin—ovarian cancer	0.0355	0.0766	CbGbCtD
Nifedipine—ABCC2—Docetaxel—ovarian cancer	0.0273	0.0588	CbGbCtD
Nifedipine—CYP3A7—Paclitaxel—ovarian cancer	0.0252	0.0543	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0252	0.0543	CbGbCtD
Nifedipine—ABCB1—Topotecan—ovarian cancer	0.0249	0.0536	CbGbCtD
Nifedipine—ABCC2—Doxorubicin—ovarian cancer	0.0204	0.0439	CbGbCtD
Nifedipine—CYP3A5—Paclitaxel—ovarian cancer	0.0189	0.0408	CbGbCtD
Nifedipine—CYP3A7—Docetaxel—ovarian cancer	0.0182	0.0393	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0182	0.0393	CbGbCtD
Nifedipine—CYP2C8—Paclitaxel—ovarian cancer	0.0182	0.0392	CbGbCtD
Nifedipine—ABCB1—Vinorelbine—ovarian cancer	0.0175	0.0378	CbGbCtD
Nifedipine—CYP2D6—Vinorelbine—ovarian cancer	0.0165	0.0356	CbGbCtD
Nifedipine—CYP3A4—Topotecan—ovarian cancer	0.0149	0.0321	CbGbCtD
Nifedipine—CYP3A5—Docetaxel—ovarian cancer	0.0137	0.0295	CbGbCtD
Nifedipine—CYP2B6—Doxorubicin—ovarian cancer	0.0129	0.0279	CbGbCtD
Nifedipine—CYP2C9—Paclitaxel—ovarian cancer	0.0127	0.0273	CbGbCtD
Nifedipine—ABCB1—Paclitaxel—ovarian cancer	0.0123	0.0265	CbGbCtD
Nifedipine—CYP3A4—Vinorelbine—ovarian cancer	0.0105	0.0226	CbGbCtD
Nifedipine—ABCB1—Docetaxel—ovarian cancer	0.0089	0.0192	CbGbCtD
Nifedipine—CYP3A4—Paclitaxel—ovarian cancer	0.00738	0.0159	CbGbCtD
Nifedipine—ABCB1—Doxorubicin—ovarian cancer	0.00663	0.0143	CbGbCtD
Nifedipine—CYP2D6—Doxorubicin—ovarian cancer	0.00625	0.0135	CbGbCtD
Nifedipine—CYP3A4—Docetaxel—ovarian cancer	0.00533	0.0115	CbGbCtD
Nifedipine—CYP3A4—Doxorubicin—ovarian cancer	0.00397	0.00857	CbGbCtD
Nifedipine—CALM2—oviduct—ovarian cancer	0.00277	0.0427	CbGeAlD
Nifedipine—CACNA1H—myometrium—ovarian cancer	0.00177	0.0272	CbGeAlD
Nifedipine—CACNA1C—myometrium—ovarian cancer	0.00135	0.0208	CbGeAlD
Nifedipine—CACNA1H—gonad—ovarian cancer	0.00116	0.0178	CbGeAlD
Nifedipine—CACNA1H—uterus—ovarian cancer	0.00115	0.0177	CbGeAlD
Nifedipine—CACNA1D—uterine cervix—ovarian cancer	0.00114	0.0175	CbGeAlD
Nifedipine—CALM3—myometrium—ovarian cancer	0.00113	0.0174	CbGeAlD
Nifedipine—CACNA1H—female reproductive system—ovarian cancer	0.00103	0.0159	CbGeAlD
Nifedipine—CACNA1C—decidua—ovarian cancer	0.001	0.0154	CbGeAlD
Nifedipine—CACNA1H—female gonad—ovarian cancer	0.000939	0.0144	CbGeAlD
Nifedipine—ABCC3—decidua—ovarian cancer	0.00091	0.014	CbGeAlD
Nifedipine—CALM2—myometrium—ovarian cancer	0.000887	0.0136	CbGeAlD
Nifedipine—CALM1—myometrium—ovarian cancer	0.000883	0.0136	CbGeAlD
Nifedipine—CACNB2—vagina—ovarian cancer	0.000881	0.0136	CbGeAlD
Nifedipine—CALM3—uterine cervix—ovarian cancer	0.000879	0.0135	CbGeAlD
Nifedipine—CACNA2D1—bone marrow—ovarian cancer	0.000864	0.0133	CbGeAlD
Nifedipine—CALM2—embryo—ovarian cancer	0.000853	0.0131	CbGeAlD
Nifedipine—CALM1—embryo—ovarian cancer	0.000849	0.0131	CbGeAlD
Nifedipine—CALM3—decidua—ovarian cancer	0.000838	0.0129	CbGeAlD
Nifedipine—CACNA1H—testis—ovarian cancer	0.000833	0.0128	CbGeAlD
Nifedipine—CACNA2D1—female gonad—ovarian cancer	0.000833	0.0128	CbGeAlD
Nifedipine—CACNA2D1—vagina—ovarian cancer	0.000828	0.0127	CbGeAlD
Nifedipine—CALM3—endometrium—ovarian cancer	0.000795	0.0122	CbGeAlD
Nifedipine—CACNB2—testis—ovarian cancer	0.000787	0.0121	CbGeAlD
Nifedipine—CACNA1C—female reproductive system—ovarian cancer	0.000786	0.0121	CbGeAlD
Nifedipine—CACNA2D1—testis—ovarian cancer	0.000739	0.0114	CbGeAlD
Nifedipine—CALM3—uterus—ovarian cancer	0.000733	0.0113	CbGeAlD
Nifedipine—ABCC3—female reproductive system—ovarian cancer	0.000715	0.011	CbGeAlD
Nifedipine—CACNA1C—vagina—ovarian cancer	0.000711	0.0109	CbGeAlD
Nifedipine—CALM2—epithelium—ovarian cancer	0.000696	0.0107	CbGeAlD
Nifedipine—CALM1—epithelium—ovarian cancer	0.000693	0.0107	CbGeAlD
Nifedipine—CYP2A6—vagina—ovarian cancer	0.000691	0.0106	CbGeAlD
Nifedipine—CALM2—uterine cervix—ovarian cancer	0.00069	0.0106	CbGeAlD
Nifedipine—CACNA1D—testis—ovarian cancer	0.000687	0.0106	CbGeAlD
Nifedipine—CALM1—uterine cervix—ovarian cancer	0.000687	0.0106	CbGeAlD
Nifedipine—CALM2—decidua—ovarian cancer	0.000658	0.0101	CbGeAlD
Nifedipine—CALM1—decidua—ovarian cancer	0.000655	0.0101	CbGeAlD
Nifedipine—ABCC3—female gonad—ovarian cancer	0.000651	0.01	CbGeAlD
Nifedipine—CACNA1C—testis—ovarian cancer	0.000635	0.00976	CbGeAlD
Nifedipine—CALM2—endometrium—ovarian cancer	0.000624	0.00961	CbGeAlD
Nifedipine—CALM3—bone marrow—ovarian cancer	0.000622	0.00957	CbGeAlD
Nifedipine—CALM1—endometrium—ovarian cancer	0.000622	0.00956	CbGeAlD
Nifedipine—CACNA1H—lymph node—ovarian cancer	0.000604	0.00929	CbGeAlD
Nifedipine—CALM3—female gonad—ovarian cancer	0.000599	0.00922	CbGeAlD
Nifedipine—CALM3—vagina—ovarian cancer	0.000596	0.00917	CbGeAlD
Nifedipine—CALM2—gonad—ovarian cancer	0.000579	0.00891	CbGeAlD
Nifedipine—ABCC3—testis—ovarian cancer	0.000577	0.00888	CbGeAlD
Nifedipine—CALM1—gonad—ovarian cancer	0.000576	0.00887	CbGeAlD
Nifedipine—CALM2—uterus—ovarian cancer	0.000575	0.00885	CbGeAlD
Nifedipine—CALM1—uterus—ovarian cancer	0.000573	0.00881	CbGeAlD
Nifedipine—ABCC2—female reproductive system—ovarian cancer	0.000572	0.00879	CbGeAlD
Nifedipine—CACNB2—lymph node—ovarian cancer	0.00057	0.00877	CbGeAlD
Nifedipine—CACNA2D1—lymph node—ovarian cancer	0.000535	0.00824	CbGeAlD
Nifedipine—CYP1A1—epithelium—ovarian cancer	0.000533	0.0082	CbGeAlD
Nifedipine—CALM3—testis—ovarian cancer	0.000532	0.00818	CbGeAlD
Nifedipine—CYP1A1—uterine cervix—ovarian cancer	0.000528	0.00813	CbGeAlD
Nifedipine—CYP2C8—endometrium—ovarian cancer	0.000517	0.00796	CbGeAlD
Nifedipine—CALM2—female reproductive system—ovarian cancer	0.000517	0.00796	CbGeAlD
Nifedipine—CYP3A5—uterine cervix—ovarian cancer	0.000516	0.00795	CbGeAlD
Nifedipine—CALM1—female reproductive system—ovarian cancer	0.000515	0.00792	CbGeAlD
Nifedipine—CACNA1D—lymph node—ovarian cancer	0.000498	0.00767	CbGeAlD
Nifedipine—CALM2—bone marrow—ovarian cancer	0.000488	0.00751	CbGeAlD
Nifedipine—CALM1—bone marrow—ovarian cancer	0.000486	0.00748	CbGeAlD
Nifedipine—CALM2—female gonad—ovarian cancer	0.000471	0.00724	CbGeAlD
Nifedipine—CALM1—female gonad—ovarian cancer	0.000468	0.00721	CbGeAlD
Nifedipine—CALM2—vagina—ovarian cancer	0.000468	0.0072	CbGeAlD
Nifedipine—CALM1—vagina—ovarian cancer	0.000466	0.00716	CbGeAlD
Nifedipine—ABCC2—testis—ovarian cancer	0.000461	0.0071	CbGeAlD
Nifedipine—CACNA1C—lymph node—ovarian cancer	0.00046	0.00708	CbGeAlD
Nifedipine—CYP1A1—uterus—ovarian cancer	0.00044	0.00677	CbGeAlD
Nifedipine—CYP2B6—gonad—ovarian cancer	0.000431	0.00662	CbGeAlD
Nifedipine—CYP2C8—female reproductive system—ovarian cancer	0.000429	0.0066	CbGeAlD
Nifedipine—ABCC3—lymph node—ovarian cancer	0.000418	0.00644	CbGeAlD
Nifedipine—CALM2—testis—ovarian cancer	0.000417	0.00642	CbGeAlD
Nifedipine—CALM1—testis—ovarian cancer	0.000416	0.00639	CbGeAlD
Nifedipine—CYP1A1—female reproductive system—ovarian cancer	0.000396	0.00609	CbGeAlD
Nifedipine—CYP2C8—vagina—ovarian cancer	0.000388	0.00597	CbGeAlD
Nifedipine—CALM3—lymph node—ovarian cancer	0.000385	0.00593	CbGeAlD
Nifedipine—CYP2B6—female reproductive system—ovarian cancer	0.000385	0.00592	CbGeAlD
Nifedipine—CYP2C9—female reproductive system—ovarian cancer	0.000381	0.00586	CbGeAlD
Nifedipine—CYP2E1—female reproductive system—ovarian cancer	0.000361	0.00555	CbGeAlD
Nifedipine—CYP1A1—female gonad—ovarian cancer	0.00036	0.00554	CbGeAlD
Nifedipine—CYP1A1—vagina—ovarian cancer	0.000358	0.00551	CbGeAlD
Nifedipine—ABCB1—myometrium—ovarian cancer	0.000353	0.00542	CbGeAlD
Nifedipine—CYP3A5—female gonad—ovarian cancer	0.000352	0.00542	CbGeAlD
Nifedipine—CYP3A5—vagina—ovarian cancer	0.00035	0.00538	CbGeAlD
Nifedipine—CYP2B6—vagina—ovarian cancer	0.000348	0.00535	CbGeAlD
Nifedipine—CYP2C8—testis—ovarian cancer	0.000346	0.00532	CbGeAlD
Nifedipine—ABCB1—embryo—ovarian cancer	0.000339	0.00522	CbGeAlD
Nifedipine—ABCC2—lymph node—ovarian cancer	0.000334	0.00514	CbGeAlD
Nifedipine—CYP2B6—testis—ovarian cancer	0.00031	0.00477	CbGeAlD
Nifedipine—CALM2—lymph node—ovarian cancer	0.000303	0.00466	CbGeAlD
Nifedipine—CALM1—lymph node—ovarian cancer	0.000301	0.00463	CbGeAlD
Nifedipine—CYP2E1—testis—ovarian cancer	0.000291	0.00448	CbGeAlD
Nifedipine—CYP3A4—female reproductive system—ovarian cancer	0.00029	0.00447	CbGeAlD
Nifedipine—CYP2D6—female reproductive system—ovarian cancer	0.000286	0.0044	CbGeAlD
Nifedipine—ABCB1—epithelium—ovarian cancer	0.000277	0.00426	CbGeAlD
Nifedipine—ABCB1—uterine cervix—ovarian cancer	0.000274	0.00422	CbGeAlD
Nifedipine—ABCB1—decidua—ovarian cancer	0.000261	0.00402	CbGeAlD
Nifedipine—CYP2D6—female gonad—ovarian cancer	0.00026	0.004	CbGeAlD
Nifedipine—ABCB1—endometrium—ovarian cancer	0.000248	0.00382	CbGeAlD
Nifedipine—CYP1A1—lymph node—ovarian cancer	0.000231	0.00356	CbGeAlD
Nifedipine—CYP2D6—testis—ovarian cancer	0.000231	0.00355	CbGeAlD
Nifedipine—ABCB1—gonad—ovarian cancer	0.00023	0.00354	CbGeAlD
Nifedipine—ABCB1—uterus—ovarian cancer	0.000229	0.00352	CbGeAlD
Nifedipine—ABCB1—female reproductive system—ovarian cancer	0.000206	0.00316	CbGeAlD
Nifedipine—ABCB1—bone marrow—ovarian cancer	0.000194	0.00299	CbGeAlD
Nifedipine—ABCB1—female gonad—ovarian cancer	0.000187	0.00288	CbGeAlD
Nifedipine—ABCB1—vagina—ovarian cancer	0.000186	0.00286	CbGeAlD
Nifedipine—Nisoldipine—ABCB1—ovarian cancer	0.000173	0.239	CrCbGaD
Nifedipine—ABCB1—testis—ovarian cancer	0.000166	0.00255	CbGeAlD
Nifedipine—Nitrendipine—ABCB1—ovarian cancer	0.000162	0.223	CrCbGaD
Nifedipine—Amlodipine—ABCB1—ovarian cancer	0.000139	0.192	CrCbGaD
Nifedipine—Felodipine—ABCB1—ovarian cancer	0.000129	0.178	CrCbGaD
Nifedipine—Nicardipine—ABCB1—ovarian cancer	0.000123	0.169	CrCbGaD
Nifedipine—ABCB1—lymph node—ovarian cancer	0.00012	0.00185	CbGeAlD
Nifedipine—Dry mouth—Docetaxel—ovarian cancer	0.000112	0.000577	CcSEcCtD
Nifedipine—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000112	0.000577	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000112	0.000576	CcSEcCtD
Nifedipine—Fatigue—Paclitaxel—ovarian cancer	0.000112	0.000575	CcSEcCtD
Nifedipine—Sweating—Epirubicin—ovarian cancer	0.000112	0.000573	CcSEcCtD
Nifedipine—Pollakiuria—Doxorubicin—ovarian cancer	0.000112	0.000573	CcSEcCtD
Nifedipine—Pain—Paclitaxel—ovarian cancer	0.000111	0.000571	CcSEcCtD
Nifedipine—Constipation—Paclitaxel—ovarian cancer	0.000111	0.000571	CcSEcCtD
Nifedipine—Haematuria—Epirubicin—ovarian cancer	0.000111	0.00057	CcSEcCtD
Nifedipine—Confusional state—Docetaxel—ovarian cancer	0.000111	0.00057	CcSEcCtD
Nifedipine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.00011	0.000567	CcSEcCtD
Nifedipine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.00011	0.000566	CcSEcCtD
Nifedipine—Anaphylactic shock—Docetaxel—ovarian cancer	0.00011	0.000566	CcSEcCtD
Nifedipine—Oedema—Docetaxel—ovarian cancer	0.00011	0.000566	CcSEcCtD
Nifedipine—Weight increased—Doxorubicin—ovarian cancer	0.00011	0.000565	CcSEcCtD
Nifedipine—Epistaxis—Epirubicin—ovarian cancer	0.00011	0.000564	CcSEcCtD
Nifedipine—Weight decreased—Doxorubicin—ovarian cancer	0.000109	0.000562	CcSEcCtD
Nifedipine—Sinusitis—Epirubicin—ovarian cancer	0.000109	0.000561	CcSEcCtD
Nifedipine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000109	0.00056	CcSEcCtD
Nifedipine—Agranulocytosis—Epirubicin—ovarian cancer	0.000109	0.000558	CcSEcCtD
Nifedipine—Shock—Docetaxel—ovarian cancer	0.000108	0.000556	CcSEcCtD
Nifedipine—Nervous system disorder—Docetaxel—ovarian cancer	0.000108	0.000555	CcSEcCtD
Nifedipine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000108	0.000554	CcSEcCtD
Nifedipine—Tachycardia—Docetaxel—ovarian cancer	0.000107	0.000552	CcSEcCtD
Nifedipine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000107	0.00055	CcSEcCtD
Nifedipine—Skin disorder—Docetaxel—ovarian cancer	0.000107	0.000549	CcSEcCtD
Nifedipine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000107	0.000549	CcSEcCtD
Nifedipine—Bradycardia—Epirubicin—ovarian cancer	0.000106	0.000547	CcSEcCtD
Nifedipine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000106	0.000546	CcSEcCtD
Nifedipine—Haemoglobin—Epirubicin—ovarian cancer	0.000105	0.00054	CcSEcCtD
Nifedipine—Jaundice—Doxorubicin—ovarian cancer	0.000105	0.000539	CcSEcCtD
Nifedipine—Anorexia—Docetaxel—ovarian cancer	0.000105	0.000539	CcSEcCtD
Nifedipine—Rhinitis—Epirubicin—ovarian cancer	0.000105	0.000538	CcSEcCtD
Nifedipine—Conjunctivitis—Doxorubicin—ovarian cancer	0.000105	0.000538	CcSEcCtD
Nifedipine—Haemorrhage—Epirubicin—ovarian cancer	0.000104	0.000537	CcSEcCtD
Nifedipine—Hepatitis—Epirubicin—ovarian cancer	0.000104	0.000537	CcSEcCtD
Nifedipine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000104	0.000534	CcSEcCtD
Nifedipine—Pharyngitis—Epirubicin—ovarian cancer	0.000104	0.000533	CcSEcCtD
Nifedipine—Sweating—Doxorubicin—ovarian cancer	0.000103	0.000531	CcSEcCtD
Nifedipine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000103	0.00053	CcSEcCtD
Nifedipine—Urticaria—Paclitaxel—ovarian cancer	0.000103	0.00053	CcSEcCtD
Nifedipine—Oedema peripheral—Epirubicin—ovarian cancer	0.000103	0.000529	CcSEcCtD
Nifedipine—Hypotension—Docetaxel—ovarian cancer	0.000103	0.000528	CcSEcCtD
Nifedipine—Haematuria—Doxorubicin—ovarian cancer	0.000103	0.000528	CcSEcCtD
Nifedipine—Connective tissue disorder—Epirubicin—ovarian cancer	0.000103	0.000528	CcSEcCtD
Nifedipine—Abdominal pain—Paclitaxel—ovarian cancer	0.000103	0.000527	CcSEcCtD
Nifedipine—Body temperature increased—Paclitaxel—ovarian cancer	0.000103	0.000527	CcSEcCtD
Nifedipine—Urethral disorder—Epirubicin—ovarian cancer	0.000102	0.000526	CcSEcCtD
Nifedipine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000102	0.000523	CcSEcCtD
Nifedipine—Epistaxis—Doxorubicin—ovarian cancer	0.000102	0.000522	CcSEcCtD
Nifedipine—Sinusitis—Doxorubicin—ovarian cancer	0.000101	0.000519	CcSEcCtD
Nifedipine—Visual impairment—Epirubicin—ovarian cancer	0.000101	0.000517	CcSEcCtD
Nifedipine—Agranulocytosis—Doxorubicin—ovarian cancer	0.0001	0.000516	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.0001	0.000515	CcSEcCtD
Nifedipine—Insomnia—Docetaxel—ovarian cancer	9.95e-05	0.000512	CcSEcCtD
Nifedipine—Paraesthesia—Docetaxel—ovarian cancer	9.88e-05	0.000508	CcSEcCtD
Nifedipine—Erythema multiforme—Epirubicin—ovarian cancer	9.88e-05	0.000508	CcSEcCtD
Nifedipine—Bradycardia—Doxorubicin—ovarian cancer	9.84e-05	0.000506	CcSEcCtD
Nifedipine—Dyspnoea—Docetaxel—ovarian cancer	9.81e-05	0.000504	CcSEcCtD
Nifedipine—Somnolence—Docetaxel—ovarian cancer	9.78e-05	0.000503	CcSEcCtD
Nifedipine—Eye disorder—Epirubicin—ovarian cancer	9.76e-05	0.000502	CcSEcCtD
Nifedipine—Tinnitus—Epirubicin—ovarian cancer	9.74e-05	0.000501	CcSEcCtD
Nifedipine—Haemoglobin—Doxorubicin—ovarian cancer	9.72e-05	0.000499	CcSEcCtD
Nifedipine—Cardiac disorder—Epirubicin—ovarian cancer	9.7e-05	0.000498	CcSEcCtD
Nifedipine—Flushing—Epirubicin—ovarian cancer	9.7e-05	0.000498	CcSEcCtD
Nifedipine—Rhinitis—Doxorubicin—ovarian cancer	9.69e-05	0.000498	CcSEcCtD
Nifedipine—Dyspepsia—Docetaxel—ovarian cancer	9.69e-05	0.000498	CcSEcCtD
Nifedipine—Haemorrhage—Doxorubicin—ovarian cancer	9.67e-05	0.000497	CcSEcCtD
Nifedipine—Hepatitis—Doxorubicin—ovarian cancer	9.67e-05	0.000497	CcSEcCtD
Nifedipine—Hypoaesthesia—Doxorubicin—ovarian cancer	9.62e-05	0.000494	CcSEcCtD
Nifedipine—Pharyngitis—Doxorubicin—ovarian cancer	9.59e-05	0.000493	CcSEcCtD
Nifedipine—Decreased appetite—Docetaxel—ovarian cancer	9.57e-05	0.000492	CcSEcCtD
Nifedipine—Hypersensitivity—Paclitaxel—ovarian cancer	9.57e-05	0.000492	CcSEcCtD
Nifedipine—Urinary tract disorder—Doxorubicin—ovarian cancer	9.55e-05	0.000491	CcSEcCtD
Nifedipine—Oedema peripheral—Doxorubicin—ovarian cancer	9.52e-05	0.000489	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Docetaxel—ovarian cancer	9.5e-05	0.000488	CcSEcCtD
Nifedipine—Connective tissue disorder—Doxorubicin—ovarian cancer	9.5e-05	0.000488	CcSEcCtD
Nifedipine—Fatigue—Docetaxel—ovarian cancer	9.49e-05	0.000488	CcSEcCtD
Nifedipine—Angiopathy—Epirubicin—ovarian cancer	9.48e-05	0.000487	CcSEcCtD
Nifedipine—Urethral disorder—Doxorubicin—ovarian cancer	9.48e-05	0.000487	CcSEcCtD
Nifedipine—Immune system disorder—Epirubicin—ovarian cancer	9.44e-05	0.000485	CcSEcCtD
Nifedipine—Mediastinal disorder—Epirubicin—ovarian cancer	9.42e-05	0.000484	CcSEcCtD
Nifedipine—Pain—Docetaxel—ovarian cancer	9.41e-05	0.000484	CcSEcCtD
Nifedipine—Constipation—Docetaxel—ovarian cancer	9.41e-05	0.000484	CcSEcCtD
Nifedipine—Chills—Epirubicin—ovarian cancer	9.37e-05	0.000482	CcSEcCtD
Nifedipine—Arrhythmia—Epirubicin—ovarian cancer	9.33e-05	0.00048	CcSEcCtD
Nifedipine—Visual impairment—Doxorubicin—ovarian cancer	9.32e-05	0.000479	CcSEcCtD
Nifedipine—Asthenia—Paclitaxel—ovarian cancer	9.31e-05	0.000479	CcSEcCtD
Nifedipine—Alopecia—Epirubicin—ovarian cancer	9.23e-05	0.000474	CcSEcCtD
Nifedipine—Pruritus—Paclitaxel—ovarian cancer	9.19e-05	0.000472	CcSEcCtD
Nifedipine—Mental disorder—Epirubicin—ovarian cancer	9.15e-05	0.00047	CcSEcCtD
Nifedipine—Erythema multiforme—Doxorubicin—ovarian cancer	9.14e-05	0.00047	CcSEcCtD
Nifedipine—Malnutrition—Epirubicin—ovarian cancer	9.09e-05	0.000467	CcSEcCtD
Nifedipine—Erythema—Epirubicin—ovarian cancer	9.09e-05	0.000467	CcSEcCtD
Nifedipine—Feeling abnormal—Docetaxel—ovarian cancer	9.07e-05	0.000466	CcSEcCtD
Nifedipine—Eye disorder—Doxorubicin—ovarian cancer	9.03e-05	0.000464	CcSEcCtD
Nifedipine—Tinnitus—Doxorubicin—ovarian cancer	9.01e-05	0.000463	CcSEcCtD
Nifedipine—Gastrointestinal pain—Docetaxel—ovarian cancer	9e-05	0.000462	CcSEcCtD
Nifedipine—Flushing—Doxorubicin—ovarian cancer	8.97e-05	0.000461	CcSEcCtD
Nifedipine—Cardiac disorder—Doxorubicin—ovarian cancer	8.97e-05	0.000461	CcSEcCtD
Nifedipine—Flatulence—Epirubicin—ovarian cancer	8.96e-05	0.000461	CcSEcCtD
Nifedipine—Tension—Epirubicin—ovarian cancer	8.92e-05	0.000459	CcSEcCtD
Nifedipine—Dysgeusia—Epirubicin—ovarian cancer	8.91e-05	0.000458	CcSEcCtD
Nifedipine—Diarrhoea—Paclitaxel—ovarian cancer	8.88e-05	0.000457	CcSEcCtD
Nifedipine—Nervousness—Epirubicin—ovarian cancer	8.83e-05	0.000454	CcSEcCtD
Nifedipine—Back pain—Epirubicin—ovarian cancer	8.8e-05	0.000452	CcSEcCtD
Nifedipine—Angiopathy—Doxorubicin—ovarian cancer	8.77e-05	0.000451	CcSEcCtD
Nifedipine—Muscle spasms—Epirubicin—ovarian cancer	8.74e-05	0.000449	CcSEcCtD
Nifedipine—Immune system disorder—Doxorubicin—ovarian cancer	8.73e-05	0.000449	CcSEcCtD
Nifedipine—Mediastinal disorder—Doxorubicin—ovarian cancer	8.71e-05	0.000448	CcSEcCtD
Nifedipine—Abdominal pain—Docetaxel—ovarian cancer	8.7e-05	0.000447	CcSEcCtD
Nifedipine—Body temperature increased—Docetaxel—ovarian cancer	8.7e-05	0.000447	CcSEcCtD
Nifedipine—Chills—Doxorubicin—ovarian cancer	8.67e-05	0.000446	CcSEcCtD
Nifedipine—Arrhythmia—Doxorubicin—ovarian cancer	8.64e-05	0.000444	CcSEcCtD
Nifedipine—Dizziness—Paclitaxel—ovarian cancer	8.59e-05	0.000441	CcSEcCtD
Nifedipine—Vision blurred—Epirubicin—ovarian cancer	8.57e-05	0.00044	CcSEcCtD
Nifedipine—Alopecia—Doxorubicin—ovarian cancer	8.54e-05	0.000439	CcSEcCtD
Nifedipine—Mental disorder—Doxorubicin—ovarian cancer	8.47e-05	0.000435	CcSEcCtD
Nifedipine—Ill-defined disorder—Epirubicin—ovarian cancer	8.44e-05	0.000434	CcSEcCtD
Nifedipine—Malnutrition—Doxorubicin—ovarian cancer	8.41e-05	0.000432	CcSEcCtD
Nifedipine—Erythema—Doxorubicin—ovarian cancer	8.41e-05	0.000432	CcSEcCtD
Nifedipine—Anaemia—Epirubicin—ovarian cancer	8.41e-05	0.000432	CcSEcCtD
Nifedipine—Agitation—Epirubicin—ovarian cancer	8.36e-05	0.00043	CcSEcCtD
Nifedipine—Flatulence—Doxorubicin—ovarian cancer	8.29e-05	0.000426	CcSEcCtD
Nifedipine—Tension—Doxorubicin—ovarian cancer	8.26e-05	0.000424	CcSEcCtD
Nifedipine—Vomiting—Paclitaxel—ovarian cancer	8.25e-05	0.000424	CcSEcCtD
Nifedipine—Dysgeusia—Doxorubicin—ovarian cancer	8.24e-05	0.000424	CcSEcCtD
Nifedipine—Malaise—Epirubicin—ovarian cancer	8.2e-05	0.000421	CcSEcCtD
Nifedipine—Rash—Paclitaxel—ovarian cancer	8.19e-05	0.000421	CcSEcCtD
Nifedipine—Dermatitis—Paclitaxel—ovarian cancer	8.18e-05	0.00042	CcSEcCtD
Nifedipine—Nervousness—Doxorubicin—ovarian cancer	8.17e-05	0.00042	CcSEcCtD
Nifedipine—Vertigo—Epirubicin—ovarian cancer	8.17e-05	0.00042	CcSEcCtD
Nifedipine—Syncope—Epirubicin—ovarian cancer	8.16e-05	0.000419	CcSEcCtD
Nifedipine—Leukopenia—Epirubicin—ovarian cancer	8.14e-05	0.000418	CcSEcCtD
Nifedipine—Back pain—Doxorubicin—ovarian cancer	8.14e-05	0.000418	CcSEcCtD
Nifedipine—Headache—Paclitaxel—ovarian cancer	8.13e-05	0.000418	CcSEcCtD
Nifedipine—Hypersensitivity—Docetaxel—ovarian cancer	8.11e-05	0.000417	CcSEcCtD
Nifedipine—Muscle spasms—Doxorubicin—ovarian cancer	8.09e-05	0.000416	CcSEcCtD
Nifedipine—Palpitations—Epirubicin—ovarian cancer	8.04e-05	0.000413	CcSEcCtD
Nifedipine—Loss of consciousness—Epirubicin—ovarian cancer	7.99e-05	0.000411	CcSEcCtD
Nifedipine—Cough—Epirubicin—ovarian cancer	7.94e-05	0.000408	CcSEcCtD
Nifedipine—Vision blurred—Doxorubicin—ovarian cancer	7.93e-05	0.000408	CcSEcCtD
Nifedipine—Asthenia—Docetaxel—ovarian cancer	7.9e-05	0.000406	CcSEcCtD
Nifedipine—Ill-defined disorder—Doxorubicin—ovarian cancer	7.81e-05	0.000401	CcSEcCtD
Nifedipine—Pruritus—Docetaxel—ovarian cancer	7.79e-05	0.0004	CcSEcCtD
Nifedipine—Anaemia—Doxorubicin—ovarian cancer	7.78e-05	0.0004	CcSEcCtD
Nifedipine—Arthralgia—Epirubicin—ovarian cancer	7.74e-05	0.000398	CcSEcCtD
Nifedipine—Chest pain—Epirubicin—ovarian cancer	7.74e-05	0.000398	CcSEcCtD
Nifedipine—Myalgia—Epirubicin—ovarian cancer	7.74e-05	0.000398	CcSEcCtD
Nifedipine—Agitation—Doxorubicin—ovarian cancer	7.73e-05	0.000397	CcSEcCtD
Nifedipine—Anxiety—Epirubicin—ovarian cancer	7.72e-05	0.000397	CcSEcCtD
Nifedipine—Nausea—Paclitaxel—ovarian cancer	7.71e-05	0.000396	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	7.69e-05	0.000395	CcSEcCtD
Nifedipine—Discomfort—Epirubicin—ovarian cancer	7.65e-05	0.000393	CcSEcCtD
Nifedipine—Malaise—Doxorubicin—ovarian cancer	7.59e-05	0.00039	CcSEcCtD
Nifedipine—Dry mouth—Epirubicin—ovarian cancer	7.57e-05	0.000389	CcSEcCtD
Nifedipine—Vertigo—Doxorubicin—ovarian cancer	7.56e-05	0.000389	CcSEcCtD
Nifedipine—Syncope—Doxorubicin—ovarian cancer	7.55e-05	0.000388	CcSEcCtD
Nifedipine—Leukopenia—Doxorubicin—ovarian cancer	7.53e-05	0.000387	CcSEcCtD
Nifedipine—Diarrhoea—Docetaxel—ovarian cancer	7.53e-05	0.000387	CcSEcCtD
Nifedipine—Confusional state—Epirubicin—ovarian cancer	7.48e-05	0.000385	CcSEcCtD
Nifedipine—Palpitations—Doxorubicin—ovarian cancer	7.44e-05	0.000382	CcSEcCtD
Nifedipine—Anaphylactic shock—Epirubicin—ovarian cancer	7.42e-05	0.000381	CcSEcCtD
Nifedipine—Oedema—Epirubicin—ovarian cancer	7.42e-05	0.000381	CcSEcCtD
Nifedipine—Loss of consciousness—Doxorubicin—ovarian cancer	7.4e-05	0.00038	CcSEcCtD
Nifedipine—Cough—Doxorubicin—ovarian cancer	7.34e-05	0.000377	CcSEcCtD
Nifedipine—Shock—Epirubicin—ovarian cancer	7.3e-05	0.000375	CcSEcCtD
Nifedipine—Nervous system disorder—Epirubicin—ovarian cancer	7.28e-05	0.000374	CcSEcCtD
Nifedipine—Dizziness—Docetaxel—ovarian cancer	7.28e-05	0.000374	CcSEcCtD
Nifedipine—Thrombocytopenia—Epirubicin—ovarian cancer	7.27e-05	0.000373	CcSEcCtD
Nifedipine—Tachycardia—Epirubicin—ovarian cancer	7.24e-05	0.000372	CcSEcCtD
Nifedipine—Skin disorder—Epirubicin—ovarian cancer	7.21e-05	0.000371	CcSEcCtD
Nifedipine—Hyperhidrosis—Epirubicin—ovarian cancer	7.18e-05	0.000369	CcSEcCtD
Nifedipine—Myalgia—Doxorubicin—ovarian cancer	7.16e-05	0.000368	CcSEcCtD
Nifedipine—Chest pain—Doxorubicin—ovarian cancer	7.16e-05	0.000368	CcSEcCtD
Nifedipine—Arthralgia—Doxorubicin—ovarian cancer	7.16e-05	0.000368	CcSEcCtD
Nifedipine—Anxiety—Doxorubicin—ovarian cancer	7.14e-05	0.000367	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	7.11e-05	0.000366	CcSEcCtD
Nifedipine—Discomfort—Doxorubicin—ovarian cancer	7.08e-05	0.000364	CcSEcCtD
Nifedipine—Anorexia—Epirubicin—ovarian cancer	7.08e-05	0.000364	CcSEcCtD
Nifedipine—Dry mouth—Doxorubicin—ovarian cancer	7.01e-05	0.00036	CcSEcCtD
Nifedipine—Vomiting—Docetaxel—ovarian cancer	7e-05	0.00036	CcSEcCtD
Nifedipine—Rash—Docetaxel—ovarian cancer	6.94e-05	0.000357	CcSEcCtD
Nifedipine—Hypotension—Epirubicin—ovarian cancer	6.94e-05	0.000356	CcSEcCtD
Nifedipine—Dermatitis—Docetaxel—ovarian cancer	6.93e-05	0.000356	CcSEcCtD
Nifedipine—Confusional state—Doxorubicin—ovarian cancer	6.92e-05	0.000356	CcSEcCtD
Nifedipine—Headache—Docetaxel—ovarian cancer	6.89e-05	0.000354	CcSEcCtD
Nifedipine—Oedema—Doxorubicin—ovarian cancer	6.87e-05	0.000353	CcSEcCtD
Nifedipine—Anaphylactic shock—Doxorubicin—ovarian cancer	6.87e-05	0.000353	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	6.76e-05	0.000348	CcSEcCtD
Nifedipine—Shock—Doxorubicin—ovarian cancer	6.76e-05	0.000347	CcSEcCtD
Nifedipine—Nervous system disorder—Doxorubicin—ovarian cancer	6.73e-05	0.000346	CcSEcCtD
Nifedipine—Thrombocytopenia—Doxorubicin—ovarian cancer	6.72e-05	0.000346	CcSEcCtD
Nifedipine—Insomnia—Epirubicin—ovarian cancer	6.71e-05	0.000345	CcSEcCtD
Nifedipine—Tachycardia—Doxorubicin—ovarian cancer	6.7e-05	0.000344	CcSEcCtD
Nifedipine—Skin disorder—Doxorubicin—ovarian cancer	6.67e-05	0.000343	CcSEcCtD
Nifedipine—Paraesthesia—Epirubicin—ovarian cancer	6.66e-05	0.000343	CcSEcCtD
Nifedipine—Hyperhidrosis—Doxorubicin—ovarian cancer	6.64e-05	0.000341	CcSEcCtD
Nifedipine—Dyspnoea—Epirubicin—ovarian cancer	6.62e-05	0.00034	CcSEcCtD
Nifedipine—Somnolence—Epirubicin—ovarian cancer	6.6e-05	0.000339	CcSEcCtD
Nifedipine—Anorexia—Doxorubicin—ovarian cancer	6.55e-05	0.000336	CcSEcCtD
Nifedipine—Nausea—Docetaxel—ovarian cancer	6.54e-05	0.000336	CcSEcCtD
Nifedipine—Dyspepsia—Epirubicin—ovarian cancer	6.53e-05	0.000336	CcSEcCtD
Nifedipine—Decreased appetite—Epirubicin—ovarian cancer	6.45e-05	0.000332	CcSEcCtD
Nifedipine—Hypotension—Doxorubicin—ovarian cancer	6.42e-05	0.00033	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Epirubicin—ovarian cancer	6.41e-05	0.000329	CcSEcCtD
Nifedipine—Fatigue—Epirubicin—ovarian cancer	6.4e-05	0.000329	CcSEcCtD
Nifedipine—Pain—Epirubicin—ovarian cancer	6.35e-05	0.000326	CcSEcCtD
Nifedipine—Constipation—Epirubicin—ovarian cancer	6.35e-05	0.000326	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	6.26e-05	0.000322	CcSEcCtD
Nifedipine—Insomnia—Doxorubicin—ovarian cancer	6.21e-05	0.000319	CcSEcCtD
Nifedipine—Paraesthesia—Doxorubicin—ovarian cancer	6.17e-05	0.000317	CcSEcCtD
Nifedipine—Dyspnoea—Doxorubicin—ovarian cancer	6.12e-05	0.000315	CcSEcCtD
Nifedipine—Feeling abnormal—Epirubicin—ovarian cancer	6.12e-05	0.000314	CcSEcCtD
Nifedipine—Somnolence—Doxorubicin—ovarian cancer	6.11e-05	0.000314	CcSEcCtD
Nifedipine—Gastrointestinal pain—Epirubicin—ovarian cancer	6.07e-05	0.000312	CcSEcCtD
Nifedipine—Dyspepsia—Doxorubicin—ovarian cancer	6.05e-05	0.000311	CcSEcCtD
Nifedipine—Decreased appetite—Doxorubicin—ovarian cancer	5.97e-05	0.000307	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	5.93e-05	0.000305	CcSEcCtD
Nifedipine—Fatigue—Doxorubicin—ovarian cancer	5.92e-05	0.000304	CcSEcCtD
Nifedipine—Urticaria—Epirubicin—ovarian cancer	5.9e-05	0.000303	CcSEcCtD
Nifedipine—Constipation—Doxorubicin—ovarian cancer	5.87e-05	0.000302	CcSEcCtD
Nifedipine—Pain—Doxorubicin—ovarian cancer	5.87e-05	0.000302	CcSEcCtD
Nifedipine—Abdominal pain—Epirubicin—ovarian cancer	5.87e-05	0.000302	CcSEcCtD
Nifedipine—Body temperature increased—Epirubicin—ovarian cancer	5.87e-05	0.000302	CcSEcCtD
Nifedipine—Feeling abnormal—Doxorubicin—ovarian cancer	5.66e-05	0.000291	CcSEcCtD
Nifedipine—Gastrointestinal pain—Doxorubicin—ovarian cancer	5.62e-05	0.000289	CcSEcCtD
Nifedipine—Hypersensitivity—Epirubicin—ovarian cancer	5.47e-05	0.000281	CcSEcCtD
Nifedipine—Urticaria—Doxorubicin—ovarian cancer	5.46e-05	0.00028	CcSEcCtD
Nifedipine—Body temperature increased—Doxorubicin—ovarian cancer	5.43e-05	0.000279	CcSEcCtD
Nifedipine—Abdominal pain—Doxorubicin—ovarian cancer	5.43e-05	0.000279	CcSEcCtD
Nifedipine—Asthenia—Epirubicin—ovarian cancer	5.33e-05	0.000274	CcSEcCtD
Nifedipine—Pruritus—Epirubicin—ovarian cancer	5.25e-05	0.00027	CcSEcCtD
Nifedipine—Diarrhoea—Epirubicin—ovarian cancer	5.08e-05	0.000261	CcSEcCtD
Nifedipine—Hypersensitivity—Doxorubicin—ovarian cancer	5.06e-05	0.00026	CcSEcCtD
Nifedipine—Asthenia—Doxorubicin—ovarian cancer	4.93e-05	0.000253	CcSEcCtD
Nifedipine—Dizziness—Epirubicin—ovarian cancer	4.91e-05	0.000252	CcSEcCtD
Nifedipine—Pruritus—Doxorubicin—ovarian cancer	4.86e-05	0.00025	CcSEcCtD
Nifedipine—Vomiting—Epirubicin—ovarian cancer	4.72e-05	0.000243	CcSEcCtD
Nifedipine—Diarrhoea—Doxorubicin—ovarian cancer	4.7e-05	0.000241	CcSEcCtD
Nifedipine—Rash—Epirubicin—ovarian cancer	4.68e-05	0.000241	CcSEcCtD
Nifedipine—Dermatitis—Epirubicin—ovarian cancer	4.68e-05	0.00024	CcSEcCtD
Nifedipine—Headache—Epirubicin—ovarian cancer	4.65e-05	0.000239	CcSEcCtD
Nifedipine—Dizziness—Doxorubicin—ovarian cancer	4.54e-05	0.000233	CcSEcCtD
Nifedipine—Nausea—Epirubicin—ovarian cancer	4.41e-05	0.000227	CcSEcCtD
Nifedipine—Vomiting—Doxorubicin—ovarian cancer	4.37e-05	0.000224	CcSEcCtD
Nifedipine—Rash—Doxorubicin—ovarian cancer	4.33e-05	0.000223	CcSEcCtD
Nifedipine—Dermatitis—Doxorubicin—ovarian cancer	4.33e-05	0.000222	CcSEcCtD
Nifedipine—Headache—Doxorubicin—ovarian cancer	4.3e-05	0.000221	CcSEcCtD
Nifedipine—Nausea—Doxorubicin—ovarian cancer	4.08e-05	0.00021	CcSEcCtD
Nifedipine—CALM1—Signaling Pathways—PIK3CG—ovarian cancer	4.37e-06	3.76e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—NRAS—ovarian cancer	4.37e-06	3.76e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—NRAS—ovarian cancer	4.37e-06	3.76e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—MAPK3—ovarian cancer	4.32e-06	3.73e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—PTEN—ovarian cancer	4.27e-06	3.68e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PIK3CB—ovarian cancer	4.25e-06	3.66e-05	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—AKT1—ovarian cancer	4.25e-06	3.66e-05	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—AKT1—ovarian cancer	4.25e-06	3.66e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	4.24e-06	3.66e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—CTNNB1—ovarian cancer	4.23e-06	3.65e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—CTNNB1—ovarian cancer	4.23e-06	3.65e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—CAV1—ovarian cancer	4.23e-06	3.65e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—CAV1—ovarian cancer	4.19e-06	3.62e-05	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—AKT1—ovarian cancer	4.19e-06	3.61e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—MAPK3—ovarian cancer	4.18e-06	3.6e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—MAPK3—ovarian cancer	4.18e-06	3.6e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PIK3CB—ovarian cancer	4.16e-06	3.59e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PIK3CB—ovarian cancer	4.15e-06	3.58e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PIK3CB—ovarian cancer	4.14e-06	3.56e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—STAT3—ovarian cancer	4.13e-06	3.56e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—PTEN—ovarian cancer	4.13e-06	3.56e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—PTEN—ovarian cancer	4.13e-06	3.56e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CD—ovarian cancer	4.13e-06	3.56e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—NRAS—ovarian cancer	4.12e-06	3.55e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—MAPK1—ovarian cancer	4.11e-06	3.54e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—EGFR—ovarian cancer	4.11e-06	3.54e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CG—ovarian cancer	4.09e-06	3.53e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.01e-06	3.45e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PIK3CB—ovarian cancer	4e-06	3.45e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PIK3CB—ovarian cancer	4e-06	3.45e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—STAT3—ovarian cancer	4e-06	3.45e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—STAT3—ovarian cancer	4e-06	3.45e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—NRAS—ovarian cancer	3.99e-06	3.44e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—NRAS—ovarian cancer	3.99e-06	3.44e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—MAPK1—ovarian cancer	3.98e-06	3.43e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—MAPK1—ovarian cancer	3.98e-06	3.43e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—EGFR—ovarian cancer	3.98e-06	3.43e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—EGFR—ovarian cancer	3.98e-06	3.43e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CD—ovarian cancer	3.97e-06	3.42e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—MAPK3—ovarian cancer	3.95e-06	3.4e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PIK3CB—ovarian cancer	3.92e-06	3.38e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—KRAS—ovarian cancer	3.88e-06	3.35e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CG—ovarian cancer	3.85e-06	3.32e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CD—ovarian cancer	3.84e-06	3.31e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CD—ovarian cancer	3.84e-06	3.31e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CG—ovarian cancer	3.82e-06	3.29e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—MAPK3—ovarian cancer	3.82e-06	3.29e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—MAPK3—ovarian cancer	3.82e-06	3.29e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—STAT3—ovarian cancer	3.82e-06	3.29e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—NRAS—ovarian cancer	3.81e-06	3.28e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	3.76e-06	3.25e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—MAPK1—ovarian cancer	3.76e-06	3.24e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—KRAS—ovarian cancer	3.76e-06	3.24e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—KRAS—ovarian cancer	3.76e-06	3.24e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—EGFR—ovarian cancer	3.76e-06	3.24e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—STAT3—ovarian cancer	3.69e-06	3.18e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—STAT3—ovarian cancer	3.69e-06	3.18e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—NRAS—ovarian cancer	3.68e-06	3.17e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—NRAS—ovarian cancer	3.68e-06	3.17e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PTEN—ovarian cancer	3.67e-06	3.17e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—MAPK3—ovarian cancer	3.65e-06	3.14e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—MAPK1—ovarian cancer	3.63e-06	3.13e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—MAPK1—ovarian cancer	3.63e-06	3.13e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—EGFR—ovarian cancer	3.63e-06	3.13e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—EGFR—ovarian cancer	3.63e-06	3.13e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CB—ovarian cancer	3.6e-06	3.1e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PTEN—ovarian cancer	3.6e-06	3.1e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.6e-06	3.1e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PTEN—ovarian cancer	3.59e-06	3.09e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CAV1—ovarian cancer	3.58e-06	3.09e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PTEN—ovarian cancer	3.57e-06	3.08e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—PIK3CA—ovarian cancer	3.57e-06	3.08e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—KRAS—ovarian cancer	3.55e-06	3.06e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—MYC—ovarian cancer	3.55e-06	3.06e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—MAPK3—ovarian cancer	3.53e-06	3.04e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—MAPK3—ovarian cancer	3.53e-06	3.04e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—ERBB2—ovarian cancer	3.5e-06	3.02e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PIK3CA—ovarian cancer	3.5e-06	3.02e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.5e-06	3.01e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—MAPK1—ovarian cancer	3.47e-06	2.99e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—EGFR—ovarian cancer	3.47e-06	2.99e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CB—ovarian cancer	3.46e-06	2.98e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MTOR—ovarian cancer	3.46e-06	2.98e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PTEN—ovarian cancer	3.46e-06	2.98e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PTEN—ovarian cancer	3.46e-06	2.98e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—PIK3CA—ovarian cancer	3.45e-06	2.98e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—PIK3CA—ovarian cancer	3.45e-06	2.98e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—TYMS—ovarian cancer	3.43e-06	2.96e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—KRAS—ovarian cancer	3.43e-06	2.96e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—KRAS—ovarian cancer	3.43e-06	2.96e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—MYC—ovarian cancer	3.43e-06	2.96e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—MYC—ovarian cancer	3.43e-06	2.96e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.42e-06	2.95e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PTEN—ovarian cancer	3.39e-06	2.92e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—ERBB2—ovarian cancer	3.39e-06	2.92e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—ERBB2—ovarian cancer	3.39e-06	2.92e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CD—ovarian cancer	3.39e-06	2.92e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CD—ovarian cancer	3.36e-06	2.9e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—MAPK1—ovarian cancer	3.36e-06	2.89e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—MAPK1—ovarian cancer	3.36e-06	2.89e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—EGFR—ovarian cancer	3.35e-06	2.89e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—EGFR—ovarian cancer	3.35e-06	2.89e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CB—ovarian cancer	3.34e-06	2.88e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MTOR—ovarian cancer	3.34e-06	2.88e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MTOR—ovarian cancer	3.34e-06	2.88e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CB—ovarian cancer	3.34e-06	2.88e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CXCL8—ovarian cancer	3.32e-06	2.86e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—HRAS—ovarian cancer	3.3e-06	2.85e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—KRAS—ovarian cancer	3.28e-06	2.82e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CG—ovarian cancer	3.26e-06	2.81e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—PIK3CA—ovarian cancer	3.26e-06	2.81e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CDKN1B—ovarian cancer	3.24e-06	2.8e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CXCL8—ovarian cancer	3.21e-06	2.77e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CXCL8—ovarian cancer	3.21e-06	2.77e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PIK3CA—ovarian cancer	3.21e-06	2.77e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—HRAS—ovarian cancer	3.19e-06	2.75e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—HRAS—ovarian cancer	3.19e-06	2.75e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CASP3—ovarian cancer	3.18e-06	2.74e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IL2—ovarian cancer	3.18e-06	2.74e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—KRAS—ovarian cancer	3.17e-06	2.73e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—KRAS—ovarian cancer	3.17e-06	2.73e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—IL6—ovarian cancer	3.16e-06	2.72e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—PIK3CA—ovarian cancer	3.15e-06	2.72e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—PIK3CA—ovarian cancer	3.15e-06	2.72e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CDKN1B—ovarian cancer	3.14e-06	2.71e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CDKN1B—ovarian cancer	3.14e-06	2.71e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CB—ovarian cancer	3.13e-06	2.7e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTEN—ovarian cancer	3.11e-06	2.68e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CCND1—ovarian cancer	3.1e-06	2.67e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CASP3—ovarian cancer	3.08e-06	2.65e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CASP3—ovarian cancer	3.08e-06	2.65e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IL2—ovarian cancer	3.07e-06	2.65e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IL2—ovarian cancer	3.07e-06	2.65e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CTNNB1—ovarian cancer	3.07e-06	2.64e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—IL6—ovarian cancer	3.06e-06	2.63e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—IL6—ovarian cancer	3.06e-06	2.63e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—HRAS—ovarian cancer	3.02e-06	2.6e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—PIK3CA—ovarian cancer	3.01e-06	2.59e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MMP9—ovarian cancer	3.01e-06	2.59e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CCND1—ovarian cancer	2.99e-06	2.58e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CCND1—ovarian cancer	2.99e-06	2.58e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PTEN—ovarian cancer	2.99e-06	2.58e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CTNNB1—ovarian cancer	2.97e-06	2.56e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CTNNB1—ovarian cancer	2.97e-06	2.56e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CB—ovarian cancer	2.95e-06	2.55e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CB—ovarian cancer	2.93e-06	2.52e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—HRAS—ovarian cancer	2.92e-06	2.52e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—HRAS—ovarian cancer	2.92e-06	2.52e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—AKT1—ovarian cancer	2.91e-06	2.51e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—PIK3CA—ovarian cancer	2.91e-06	2.51e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—PIK3CA—ovarian cancer	2.91e-06	2.51e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MMP9—ovarian cancer	2.91e-06	2.51e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MMP9—ovarian cancer	2.91e-06	2.51e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PTEN—ovarian cancer	2.89e-06	2.49e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PTEN—ovarian cancer	2.89e-06	2.49e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IL6—ovarian cancer	2.89e-06	2.49e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CD—ovarian cancer	2.87e-06	2.47e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—AKT1—ovarian cancer	2.86e-06	2.47e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—AKT1—ovarian cancer	2.82e-06	2.43e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—AKT1—ovarian cancer	2.82e-06	2.43e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IL6—ovarian cancer	2.79e-06	2.41e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IL6—ovarian cancer	2.79e-06	2.41e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—HRAS—ovarian cancer	2.78e-06	2.4e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CAV1—ovarian cancer	2.77e-06	2.38e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTEN—ovarian cancer	2.71e-06	2.33e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—VEGFA—ovarian cancer	2.7e-06	2.33e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—HRAS—ovarian cancer	2.69e-06	2.32e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—HRAS—ovarian cancer	2.69e-06	2.32e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—STAT3—ovarian cancer	2.67e-06	2.3e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—NRAS—ovarian cancer	2.67e-06	2.3e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—IL6—ovarian cancer	2.67e-06	2.3e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—AKT1—ovarian cancer	2.66e-06	2.3e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—AKT1—ovarian cancer	2.62e-06	2.26e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—VEGFA—ovarian cancer	2.61e-06	2.25e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—VEGFA—ovarian cancer	2.61e-06	2.25e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PIK3CA—ovarian cancer	2.59e-06	2.23e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—STAT3—ovarian cancer	2.58e-06	2.23e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—STAT3—ovarian cancer	2.58e-06	2.23e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—NRAS—ovarian cancer	2.58e-06	2.22e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—NRAS—ovarian cancer	2.58e-06	2.22e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—IL6—ovarian cancer	2.58e-06	2.22e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—IL6—ovarian cancer	2.58e-06	2.22e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—AKT1—ovarian cancer	2.58e-06	2.22e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—AKT1—ovarian cancer	2.58e-06	2.22e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MAPK3—ovarian cancer	2.55e-06	2.2e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTEN—ovarian cancer	2.55e-06	2.2e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PIK3CA—ovarian cancer	2.54e-06	2.19e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PIK3CA—ovarian cancer	2.53e-06	2.18e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTEN—ovarian cancer	2.53e-06	2.18e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PIK3CA—ovarian cancer	2.52e-06	2.17e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.52e-06	2.17e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CB—ovarian cancer	2.5e-06	2.16e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MYC—ovarian cancer	2.48e-06	2.14e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MAPK3—ovarian cancer	2.47e-06	2.13e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MAPK3—ovarian cancer	2.47e-06	2.13e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—AKT1—ovarian cancer	2.46e-06	2.12e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PIK3CA—ovarian cancer	2.44e-06	2.1e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PIK3CA—ovarian cancer	2.44e-06	2.1e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MAPK1—ovarian cancer	2.43e-06	2.09e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—EGFR—ovarian cancer	2.43e-06	2.09e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MYC—ovarian cancer	2.4e-06	2.07e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MYC—ovarian cancer	2.4e-06	2.07e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PIK3CA—ovarian cancer	2.39e-06	2.06e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—AKT1—ovarian cancer	2.38e-06	2.05e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—AKT1—ovarian cancer	2.38e-06	2.05e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MAPK1—ovarian cancer	2.35e-06	2.03e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MAPK1—ovarian cancer	2.35e-06	2.03e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—EGFR—ovarian cancer	2.35e-06	2.03e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—EGFR—ovarian cancer	2.35e-06	2.03e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—KRAS—ovarian cancer	2.29e-06	1.98e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—KRAS—ovarian cancer	2.22e-06	1.91e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—KRAS—ovarian cancer	2.22e-06	1.91e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.22e-06	1.91e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CA—ovarian cancer	2.19e-06	1.89e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTEN—ovarian cancer	2.16e-06	1.86e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—AKT1—ovarian cancer	2.12e-06	1.82e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CA—ovarian cancer	2.11e-06	1.82e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—AKT1—ovarian cancer	2.07e-06	1.79e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—AKT1—ovarian cancer	2.07e-06	1.78e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—AKT1—ovarian cancer	2.06e-06	1.78e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TP53—ovarian cancer	2.04e-06	1.76e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CA—ovarian cancer	2.04e-06	1.76e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CA—ovarian cancer	2.04e-06	1.76e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—AKT1—ovarian cancer	1.99e-06	1.72e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—AKT1—ovarian cancer	1.99e-06	1.72e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TP53—ovarian cancer	1.97e-06	1.7e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TP53—ovarian cancer	1.97e-06	1.7e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—AKT1—ovarian cancer	1.95e-06	1.68e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—HRAS—ovarian cancer	1.95e-06	1.68e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.93e-06	1.66e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CA—ovarian cancer	1.91e-06	1.65e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—HRAS—ovarian cancer	1.89e-06	1.63e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—HRAS—ovarian cancer	1.89e-06	1.63e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IL6—ovarian cancer	1.87e-06	1.61e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IL6—ovarian cancer	1.81e-06	1.56e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IL6—ovarian cancer	1.81e-06	1.56e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CA—ovarian cancer	1.8e-06	1.55e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—AKT1—ovarian cancer	1.79e-06	1.54e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CA—ovarian cancer	1.78e-06	1.54e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—AKT1—ovarian cancer	1.72e-06	1.48e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTEN—ovarian cancer	1.67e-06	1.44e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—AKT1—ovarian cancer	1.67e-06	1.44e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—AKT1—ovarian cancer	1.67e-06	1.44e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—AKT1—ovarian cancer	1.56e-06	1.35e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CA—ovarian cancer	1.53e-06	1.31e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—AKT1—ovarian cancer	1.47e-06	1.27e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—AKT1—ovarian cancer	1.46e-06	1.26e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—AKT1—ovarian cancer	1.25e-06	1.07e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.18e-06	1.01e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—AKT1—ovarian cancer	9.62e-07	8.29e-06	CbGpPWpGaD
